Experimental Nuclear Medicine Meets Tumor Biology

Pharmaceuticals (Basel). 2022 Feb 14;15(2):227. doi: 10.3390/ph15020227.


Personalized treatment of cancer patients demands specific and validated biomarkers for tumor diagnosis and therapy. The development and validation of such require translational preclinical models that recapitulate human diseases as accurately as possible. Moreover, there is a need for convergence of different (pre)clinical disciplines that openly share their knowledge and methodologies. This review sheds light on the differential perception of biomarkers and gives an overview of currently used models in tracer development and approaches for biomarker discovery.

Keywords: animal models; biomarker imaging; cancer biomarkers; in vitro models; molecular imaging; molecular pathology; tracer development.

Publication types

  • Review